Researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also being able to deliver healing agents in one simple, scalable platform.

BioVersys receives US FDA nod to recruit US patients for BV100 HABP/VABP phase 3 trial to treat hospital-acquired or ventilator-associated bacterial pneumonia: Basel, Switzerland ...

Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026Obtained alignment with FDA and ...

Researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also being ...

Zinc supplements are widely used to boost immunity and treat deficiencies, but taking too much can cause nausea, nutrient ...

So, Microsoft’s been working on something pretty big in the quantum computing world. They’ve developed this new ...